Company intelligence / Profile preview

Darkfin Labs

New York, New York, United Statesdarkfinlabs.com ↗
Ownership
Private
Development stage
Other
01

Overview

Darkfin Labs is a longevity-focused biotech skincare company that develops advanced anti-aging and preventative skincare products. Founded by stem cell biologist Annalina Che, the company's formulations are built around L-01™ (also known as DL-01™), a proprietary, plant-grown growth factor peptide complex inspired by stem cell signaling science. This complex contains precisely dosed, bio-designed growth factors—including epidermal growth factor (EGF), fibroblast growth factor 2 (FGF-2), and insulin-like growth factor 1 (IGF-1)—produced via plant-based protein expression and encapsulated in a plant-derived liposomal delivery system. Darkfin Labs' flagship product, the Longevity Protocol Serum + Moisturizer, is a multitasking daily formula designed to target multiple pathways of skin aging, such as collagen decline, chronic inflammation, and barrier impairment. The company's research arm, Stemtology, collaborates with Microsoft's AI Co-Innovation Labs to leverage agentic AI and machine learning to accelerate regenerative medicine and biomimetic discovery.

Therapeutic areas
DermatologyImmunology
Modalities
PeptidesBiologicRecombinant protein
Industry
Non-Drug Biotech
02

Partnerships

Ulta BeautyMicrosoft

Beyond the preview

Go deeper on Darkfin Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Darkfin Labs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call